BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37064092)

  • 1. Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).
    Meagher MF; Mir MC; Minervini A; Kriegmair M; Heck M; Porpiglia F; Van Bruwaene S; Linares E; Hevia V; D'Anna M; Veccia A; Roussel E; Claps F; Palumbo C; Marchioni M; Afari J; Saitta C; Liu F; Rubio J; Campi R; Mari A; Amiel T; Checcucci E; Musquera M; Guruli G; Pavan N; Albersen M; Antonelli A; Klatte T; Autorino R; McKay RR; Derweesh IH
    Front Oncol; 2023; 13():1113246. PubMed ID: 37064092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry.
    Meagher MF; Mir MC; Autorino R; Minervini A; Kriegmair M; Maurer T; Porpiglia F; Van Bruwaene S; Linares E; Hevia V; Musquera M; Roussel E; Pavan N; Antonelli A; Zhang S; Ghali F; Patel D; Javier-Desloges J; Bradshaw A; Rubio J; Guruli G; Tracey A; Campi R; Albersen M; Furlan M; McKay RR; Derweesh IH
    Clin Genitourin Cancer; 2022 Aug; 20(4):326-333. PubMed ID: 35585014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC).
    Marchioni M; Kriegmair M; Heck M; Amiel T; Porpiglia F; Ceccucci E; Campi R; Minervini A; Mari A; Van Bruwaene S; Linares E; Hevia V; Musquera M; D'Anna M; Derweesh I; Bradshaw A; Autorino R; Guruli G; Veccia A; Roussel E; Albersen M; Pavan N; Claps F; Antonelli A; Palumbo C; Klatte T; Erdem S; Mir MC;
    Eur Urol Oncol; 2021 Apr; 4(2):256-263. PubMed ID: 33384274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging.
    Yu KJ; Keskin SK; Meissner MA; Petros FG; Wang X; Borregales LD; Gu C; Tamboli P; Matin SF; Wood CG; Karam JA
    Cancer; 2018 Oct; 124(20):4023-4031. PubMed ID: 30276798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the REMARCC model for the selection of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma: A multicenter retrospective study.
    Okita K; Hatakeyama S; Naito S; Numakura K; Kato R; Koguchi T; Kojima T; Kawasaki Y; Kandori S; Kawamura S; Nishiyama H; Ito A; Kojima Y; Habuchi T; Obara W; Tsuchiya N; Ohyama C
    Urol Oncol; 2021 Dec; 39(12):836.e11-836.e17. PubMed ID: 34544649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience.
    Choi CI; Kang M; Sung HH; Jeon HG; Jeong BC; Jeon SS; Lee HM; Seo SIL
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1189-e1199. PubMed ID: 30262447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive lymph node ratio predicts adverse prognosis for patients with lymph nodes metastatic hypopharyngeal squamous cell carcinoma after primary surgery.
    Wang K; Tian W; Xu X; Peng X; Tang H; Zhao Y; Wang X; Li G
    Transl Cancer Res; 2022 Mar; 11(3):463-474. PubMed ID: 35402181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Extrarenal Invasion Patterns and Tumor Size with the Differences in Survival Outcomes of T3a Renal Cell Carcinoma: A Proposal Modified T3a Stage System is Needed.
    Wu X; Wang Q; Wang Z; Zhao X; Xu X
    Int J Gen Med; 2022; 15():367-378. PubMed ID: 35027844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Patterns of Perirenal Fat Invasion Are Associated With a Poorer Prognosis Compared With Isolated Invasion: A Proposal for a Revision of T3aN0M0 TNM Staging System.
    Wang Z; Yu K; Zhu Y; Feng C; Liu C; Liu S; Wang J; Zeng X
    Front Oncol; 2020; 10():336. PubMed ID: 32219068
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of preoperative serum De Ritis ratio with oncological outcomes in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Laukhtina E; Pradere B; D Andrea D; Rosiello G; Luzzago S; Pecoraro A; Palumbo C; Knipper S; Karakiewicz PI; Margulis V; Quhal F; Sari Motlagh R; Mostafaei H; Mori K; Kimura S; Enikeev D; Shariat SF
    Urol Oncol; 2020 Dec; 38(12):936.e7-936.e14. PubMed ID: 32962909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.
    Hamilton ZA; Capitanio U; Pruthi D; Ghali F; Larcher A; Patel DN; Eldefrawy A; Patel S; Cotta BH; Bradshaw AW; Meagher MF; Miller NS; Carenzi C; Wan F; Liss MA; McGregor T; Montorsi F; Derweesh IH
    Urology; 2020 Apr; 138():60-68. PubMed ID: 31836465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
    Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
    Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
    Xue W; Zhang Y; Wang H; Zhang Y; Hu X
    Front Immunol; 2021; 12():778746. PubMed ID: 34917092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
    DiNatale RG; Xie W; Becerra MF; Silagy AW; Attalla K; Sanchez A; Mano R; Marcon J; Blum KA; Benfante NE; Voss MH; Motzer RJ; Coleman J; Choueiri TK; Reznik E; Russo P; Heng DYC; Hakimi AA
    Eur Urol Oncol; 2020 Feb; 3(1):47-56. PubMed ID: 31735646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomograms for predicting overall survival and cause-specific survival of signet ring cell carcinoma in colorectal cancer patients.
    Kou FR; Zhang YZ; Xu WR
    World J Clin Cases; 2021 Apr; 9(11):2503-2518. PubMed ID: 33889615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1-2M1 renal cell carcinoma.
    Tian J; Zeng X; Zhu J; Guan W; Hu Z; Yang C
    Transl Cancer Res; 2023 Feb; 12(2):301-309. PubMed ID: 36915574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
    Cerrato C; Patel D; Autorino R; Simone G; Yang B; Uzzo R; Porpiglia F; Capitanio U; Porter J; Beksac AT; Minervini A; Antonelli A; Cerruto MA; Lau C; Ashrafi A; Eun D; Mottrie A; Mir C; Meagher MF; Puri D; Nguyen M; Dhanji S; Liu F; Pandolfo SD; Kutikov A; Montorsi F; Gill IS; Sundaram C; Kaouk J; Derweesh IH
    World J Urol; 2023 Mar; 41(3):747-755. PubMed ID: 36856832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.
    de Velasco G; Culhane AC; Fay AP; Hakimi AA; Voss MH; Tannir NM; Tamboli P; Appleman LJ; Bellmunt J; Kimryn Rathmell W; Albiges L; Hsieh JJ; Heng DY; Signoretti S; Choueiri TK
    Oncologist; 2017 Mar; 22(3):286-292. PubMed ID: 28220024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review.
    Kovac E; Firoozbakhsh F; Zargar H; Fergany A; Elsharkawy H
    Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.